Yokneam's Rapid Medical Announces FDA Clearance of DRIVEWIRE™ 35 and First Stroke Cases

Yokneam's Rapid Medical Announces FDA Clearance of DRIVEWIRE™ 35 and First Stroke Cases

First steerable 0.035-inch guidewire combines controlled tip deflection and distal support to accelerate catheter access; builds on nearly 5,000 DRIVEWIRE™ 24 cases. Jeremy Rempel, MD, of the University of Alberta Hospital in Edmonton, Canada, performed the first clinical cases worldwide, including successfully navigating catheters to treat an intracranial occlusion without crossing the clot.

HemoScreen Deployed Across More Than 1/3 of NHS Mental Health Trusts

HemoScreen Deployed Across More Than 1/3 of NHS Mental Health Trusts

More than one-third of NHS mental health trusts across the United Kingdom have now adopted PixCell Medical's HemoScreen point-of-care complete blood count (CBC) analyzer, marking one of the fastest known expansions of near-patient hematology within UK mental health services. Initially introduced through targeted evaluations and clozapine monitoring pilots, HemoScreen has rapidly expanded into routine clinical practice across community mental health clinics, inpatient wards and secure psychiatric units.

InMode (NASDAQ: INMD) outlines 2026 AGM agenda, RSU grants and committee fees

InMode (NASDAQ: INMD) outlines 2026 AGM agenda, RSU grants and committee fees

InMode Ltd. has called its annual general meeting for July 30, 2026, at 17:00 Israel time in Yokneam. Shareholders will vote on four items: re-electing Class I director Dr. Hadar Ron, re-appointing PwC as auditor for 2026, granting a total of 6,000 restricted share units to three non-executive directors, and approving the compensation terms for a special board committee that evaluated a potential sale process.

Nvidia’s Mellanox bet keeps paying off as quarterly networking revenue hits $11 billion

Nvidia’s Mellanox bet keeps paying off as quarterly networking revenue hits $11 billion

When Nvidia paid $6.9 billion in 2020 to acquire Mellanox Technologies, an Israeli specialist in high-speed communications chips, the deal was framed as a strategic complement to its dominant graphics processors. Six years later, that acquisition has become one of the most consequential bets in the company’s history.